Varicella vaccination in Japan, South Korea, and Europe

Catherine Sadzot-Delvaux, Bernard Rentier, Peter Wutzler, Yoshizo Asano, Sadao Suga, Tetsushi Yoshikawa, Stanley A. Plotkin

研究成果: Article査読

53 被引用数 (Scopus)

抄録

The most extensive use of varicella vaccine has been in the United States and Canada, where it is universally recommended. However, a number of other countries now have recommendations for use of the vaccine, which has been expanding in Europe and Latin America. In this article, we review information concerning varicella vaccination in Japan, where the vaccine was first developed, and in South Korea and parts of Europe. Despite the worldwide availability of an efficient vaccine, varicella vaccination policy is highly variable from country to country. The recent development of a tetravalent vaccine against measles, mumps, rubella, and varicella could modify this variability in the future. It is evident that efforts to control varicella will spread gradually to all continents.

本文言語English
ページ(範囲)S185-S190
ジャーナルJournal of Infectious Diseases
197
SUPPL. 2
DOI
出版ステータスPublished - 01-03-2008

All Science Journal Classification (ASJC) codes

  • 免疫アレルギー学
  • 感染症

フィンガープリント

「Varicella vaccination in Japan, South Korea, and Europe」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル